Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines do not increase the risk of alopecia areata.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Scientists created a 3D skin model to study a chronic skin disease and test treatments.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

CGF therapy may effectively treat psoriasis by reducing inflammation.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.